Cartalax
Also known as Cartalax peptide, Cartilage bioregulator
Cartalax is a synthetic short peptide in the Russian bioregulator family, distinguished by a connective-tissue and cartilage research emphasis. A research-use profile distinct from epitalon and pinealon.
Cartalax rounds out the trio of short 'peptide bioregulators' most often seen together — epitalon, pinealon, and cartalax — but it earns its own page through its tissue emphasis. Its very name points to the system it is studied against: cartilage and connective tissue.
That focus is the whole reason to treat cartalax separately from its relatives. Where epitalon is discussed against a pineal and telomere backdrop and pinealon against neural tissue, cartalax is examined in connective-tissue research contexts. This page describes that positioning and the family it belongs to, and keeps to research areas rather than outcomes.
Cartalax is a synthetic short peptide from the same Russian bioregulator program as epitalon and pinealon. Its distinguishing feature within that family is its association with connective-tissue and cartilage research rather than the pineal or neural emphasis of its relatives. (We list a verified sequence only where we are certain of it; where a certificate of analysis defines the exact residues for a given lot, that is the reference to use.)
The connective-tissue member of the family
The peptide bioregulator program produced a set of short synthetic sequences, each associated in the literature with a particular tissue system. Cartalax is the one linked to cartilage and connective tissue — a different emphasis from the pineal-associated epitalon and the neurally-focused pinealon.
Grouping these peptides by their shared design and lineage is accurate. Assigning each a promised effect is not — the tissue labels describe where researchers have looked, not what the molecule does for anyone.
Reading a cartalax certificate of analysis
Short peptides are straightforward to characterize, and cartalax is no exception: a mass-spectrometry trace should agree with a small, well-defined mass, and an HPLC trace should resolve to a dominant single peak. Because cartalax is less thoroughly documented in mainstream chemistry databases than some peptides, the per-lot certificate is the authoritative reference for the exact residues and mass of what you hold. Look for the method and a batch identifier, not just a headline purity number. Every lot we list is tied to its own certificate.
These are research areas the compound is associated with in the literature — not medical claims or intended uses.
Handling & storage
Supplied lyophilized. Kept sealed and cold; in research settings it is reconstituted with bacteriostatic water only when a protocol requires it, then refrigerated. Handle per accepted laboratory practice.
Verify a certificate by lot →Common questions
All three come from the same Russian short-peptide bioregulator family, but each has a different tissue emphasis in the literature. Cartalax is associated with cartilage and connective tissue, epitalon with pineal and telomere research, and pinealon with neural tissue.
We publish a sequence only where we are certain of it. Cartalax is less thoroughly documented in mainstream chemistry databases than some peptides, so we defer to the exact residues and mass stated on the certificate of analysis for each specific lot.
Connective-tissue and cartilage research contexts. That emphasis is what distinguishes it from the other peptides in its family.
This monograph is a research-use reference. It describes composition and the contexts in which the compound has been studied — it is not medical advice, a description of effects, or a recommendation for use. Sold strictly for laboratory and research use; not for human or animal consumption.